Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of MM36 (Difamilast) Ointment in Pediatric Atopic Dermatitis
NCT02945657Phase 2Completed
- Sponsor
- Medimetriks Pharmaceuticals, Inc.
- Start
- Oct 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of difamilast in atopic dermatitis (AD), sponsored by Medimetriks Pharmaceuticals, Inc.. Started Oct 2016; status: completed.
02
Drugs
difamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02945657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02945657.